Evidence map›Paper›PMID 27496760›Full record

ArticleGlycobiology2017

Cryptococcus neoformans UGT1 encodes a UDP-Galactose/UDP-GalNAc transporter.

Lucy X Li, Angel Ashikov, Hong Liu, Cara L Griffith, Hans Bakker, Tamara L Doering

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Salt Stress Accelerates Tyrosine Depletion byFoods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. C1GALT1 in health and disease.Oncology letters · 2021
    Review
  8. Review
  9. Dangerous Liaisons: Interactions ofPathogens (Basel, Switzerland) · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Titan cell production inCell surface (Amsterdam, Netherlands) · 2018
    Article
  14. Article
  15. Peeling the onion: the outer layers of Cryptococcus neoformans.Memorias do Instituto Oswaldo Cruz · 2018
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lucy X LiDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Angel AshikovDepartment of Cellular Chemistry, Hannover Medical School, D-30625 Hannover, Germany.
Hong LiuDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Cara L GriffithDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Hans BakkerDepartment of Cellular Chemistry, Hannover Medical School, D-30625 Hannover, Germany.
Tamara L DoeringDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA doering@wustl.edu.
Washington University in St. Louis · USMedizinische Hochschule Hannover · DE

Funding

CAPSULE REGULATION AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANSR01AI087794 · NIAID · WASHINGTON UNIVERSITY · PI BRENT, MICHAEL R, DOERING, TAMARA L · 2011 to 2020
$4.1M
GLYCAN BIOSYNTHESIS IN CRYPTOCOCCUS NEOFORMANSR01GM071007 · NIGMS · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2004 to 2010
$1.9M
GLYCAN PRECURSOR TRANSPORT IN CRYPTOCOCCUS NEOFORMANSR21AI109623 · NIAID · WASHINGTON UNIVERSITY · PI DOERING, TAMARA L · 2014 to 2015
$419k
Role of glycan precursor transporters in Cryptococcus neoformans virulenceF30AI120339 · NIAID · WASHINGTON UNIVERSITY · PI LI, LUCY · 2016 to 2018
$128k
NIAID NIH HHS F30 AI120339NIAID NIH HHS R01 AI087794NIAID NIH HHS R21 AI109623NIGMS NIH HHS R01 GM071007
6 · The paper itself

Abstract

Cryptococcus neoformans, an opportunistic fungal pathogen, produces a glycan capsule to evade the immune system during infection. This definitive virulence factor is composed mainly of complex polysaccharides, which are made in the secretory pathway by reactions that utilize activated nucleotide sugar precursors. Although the pathways that synthesize these precursors are known, the identity and the regulation of the nucleotide sugar transporters (NSTs) responsible for importing them into luminal organelles remain elusive. The UDP-galactose transporter, Ugt1, was initially identified by homology to known UGTs and glycan composition analysis of ugt1Δ mutants. However, sequence is an unreliable predictor of NST substrate specificity, cells may express multiple NSTs with overlapping specificities, and NSTs may transport multiple substrates. Determining NST activity thus requires biochemical demonstration of function. We showed that Ugt1 transports both UDP-galactose and UDP-N-acetylgalactosamine in vitro. Deletion of UGT1 resulted in growth and mating defects along with altered capsule and cellular morphology. The mutant was also phagocytosed more readily by macrophages than wild-type cells and cleared more quickly in vivo and in vitro, suggesting a mechanism for the lack of virulence observed in mouse models of infection.

Indexed as

Amino Acid SequenceAnimalsBiological TransportCryptococcosisCryptococcus neoformansDisease Models, AnimalGalactoseHumansMiceMonosaccharide Transport ProteinsPolysaccharidesSubstrate SpecificityUDP-Galactose TranslocatorsUridine Diphosphate GalactoseGalactoseMonosaccharide Transport ProteinsPolysaccharidesUDP-Galactose TranslocatorsUridine Diphosphate GalactoseCryptococcus neoformansnucleotide sugar transporterspolysaccharide capsuleUDP-galactoseUDP-GalNAc

Identifiers

PMID27496760
PMCPMC5193108
OpenAlexW2505906622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.